Greenbrook TMS Inc. (GBNH) Research

Greenbrook TMS Inc., and its associated entities, oversees and runs a broad array of outpatient mental healthcare centers throughout the United States. These specialized clinics primarily deliver transcranial magnetic stimulation (TMS) therapy, an FDA-approved, non-surgical treatment effective for major depressive disorder and various other mental health conditions. Additionally, they provide a suite of related psychiatric services. By the close of 2021, the company's operational reach extended to 149 TMS centers (94 wholly owned and 55 other facilities) dispersed across 17 U.S. states. These states include Virginia, Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Market snapshot

Symbol
GBNH
Price
$0.12
Day change
-40.69%
Market cap
$5.5M
P/E ratio
-0.03x
52-week range
0.03765-1.47
Sector
Healthcare
Industry
Medical - Care Facilities

Peer companies

  • Entero Therapeutics, Inc. (ENTO)
  • LumiraDx Limited (LMDX)
  • ModivCare Inc. (MODV)
  • NanoString Technologies, Inc. (NSTG)
  • Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)
  • Invitae Corporation (NVTA)
  • Regional Health Properties, Inc. (RHE)
  • Regional Health Properties, Inc. (RHEP)

Recent insider activity

  • Crish Andrew — A-Award (250000 shares) on 2024-04-01
  • Willett Peter Casimir — A-Award (300000 shares) on 2024-04-01
  • Crish Andrew — trade (0 shares) on 2024-03-04
  • Elstad Juliana — trade (0 shares) on 2024-01-23
  • Madryn Asset Management, LP — trade (0 shares) on 2024-01-01

Open Greenbrook TMS Inc. (GBNH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.